XBP1 and serum lipopolysaccharide activity: Elaboration of the HIF-1α/miR-674-5p/XBP-1 signaling pathway not only provides novel and important insight into the pathogenesis of intestinal injury by endotoxemia or endotoxemia, but also suggests a novel miRNA-based therapeutic target for prevention and treatment.